Alepride
- Level
- Commodity
- Parent
- 51171800
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171826This classification denotes an antiemetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R6G1M06TPO. European Medicines Agency schedules Alepride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05309MIG. Alepride generally arises in the molecular formula C22H30CLN3O2. The term ALEPRIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, no. 10 1979, list 19.) ALEPRIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule alepride under HS 29333999 and SITC 51574. As of Q4 2014, ALEPRIDE remains the US FDA Preferred Term for this commodity. Alepride bears US NLM identifiers UMLS ID C2697984 and NCI Concept Code C74450. SMILES: CLC1CC(C(=O)NC2CCN(CC3CCC=CC3)CC2)C(OCC=C)CC1N.
Same parent
Under 51171800 · 49Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.